Portola Pharmaceuticals
PTLA
#5330
Rank
NZ$2.45 B
Marketcap
NZ$31.27
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Portola Pharmaceuticals (PTLA)

Earnings in 2020 (TTM): -NZ$0.39 Billion

According to Portola Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.12 Billion. In 2019 the company made an earning of -NZ$0.46 Billion, an increase over its 2018 earnings that were of -NZ$0.58 Billion.

Earnings history for Portola Pharmaceuticals from 2012 to 2020

Annual earnings

Year Earnings Change
2020 (TTM)-NZ$0.39 Billion-15.11%
2019-NZ$0.46 Billion-21.16%
2018-NZ$0.58 Billion21.74%
2017-NZ$0.48 Billion1.1%
2016-NZ$0.47 Billion18.67%
2015-NZ$0.4 Billion65.14%
2014-NZ$0.24 Billion65.04%
2013-NZ$0.15 Billion-833.35%
2012NZ$19.7 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$58.18 B-13,606.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$17.67 B-4,202.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.35 B-3,199.44%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$2.69 B-726.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.17 B-3,855.10%๐Ÿ‡บ๐Ÿ‡ธ USA